SlideShare a Scribd company logo
1 of 14
Download to read offline
Open access
    social media
   guidelines for
      pharma
                     December, 2011
                      First version


„A set of guidelines created collaboratively by the most important
 online voices of pharma and social media designed to facilitate
            online interaction with and within pharma.”

                                       #pharmaSMguide
Open access social media
                                                 guidelines for pharma



                           Table of contents

1) Introduction................................................................2
2) A Physician’s Rules of Engagement...........................3
3) Pharma’s Rules of Engagement..................................4
4) How pharma should use social media........................5
5) How pharma should use Wikipedia...........................7
6) How pharma should use Facebook.............................8
7) How pharma should use Twitter.................................9
8) How pharma should write blogs...............................10
9) How pharma should use Youtube..............................11
10) Acknowledgement...................................................12
11) Contact addresses....................................................13




                                                                              1
Open access social media
                                                                guidelines for pharma



            1                                 Introduction
FDA and other authorities have been trying to deal with the rapid adoption of social media but they have
not been able to publish the required guidance about how pharma can engage with social media.

At Webicina.com, we decided to launch a project with a mission of creating a set of open access social
media guidelines for and about the pharma industry with the help of an expert crowd.

This is "the key principles in a manifesto type document" which can be the overview for pharma to
follow. The guidance outlines the key principles such as protecting patients, keeping healthcare
professionals informed, being transparent, reporting the Adverse Events, or following applicable codes
and regulations in social media.

After months of hard collaborative work, we now publish „A Physician’s Rules of Engagement”; a
„Pharma’s Rules of Engagement”; Key Principles about how pharma should use social media and
technology specific guides as well.

We hope this guide will initiate an even more extended collaboration and we, healthcare professionals,
e-patients and pharma, can facilitate the process for the FDA of publishing its own guide.

Show your support or feedback your thoughts on Twitter using #pharmaSMguide.

Join this project and see more details including positive and negative pharma-related social media case
studies on Webicina!

Best regards,

Dr. Bertalan Mesko
Managing director of Webicina.com

&

Dr. Felix Jackson
Chief Medical Officer of medDigital




                                                                                                      2
Open access social media
                                                              guidelines for pharma



            2                        A Physician’s Rules of
                                         Engagement
                               A physician's perspective on how pharma
                             should engage with physicians in social media

1) Work with me to improve my patient's care:

•Understand my needs. Make it easy for me to access your expertise and listen to me online.
•Engage with me. Don't just promote or try to influence me.
•Communicate with me. Using both online and offline channels.
•Protect my private data. Both my personal data and my clinical research data.
•Get my permission. You have my permission when I've given it to you.

2) Keep our patients safe:

•Conduct ethical research. And communicate your successes online.
•Manufacture the best medicines. Maintaining the highest standards of quality.
•Market only licensed medicines. And keep me informed even online about those in development.
•Be transparent in everything you do. Or someone else will be on your behalf!
•Improve your knowledge. Understand and report adverse events on your medicines by listening
online.

3) Work with each other:

•Stay within your codes and regulations. Use these principles with your codes and regulations to
understand your responsibilities.
•Share your learnings. Share your metrics to identify success and understand failure across the
industry.
•Improve your codes and regulations. Give and share feedback to improve these principles. Use these
principles to revise your codes and regulations.




                                                                                                 3
Open access social media
                                                             guidelines for pharma



            3                             Pharma’s Rules of
                                            Engagement
                                 Pharma’s perspective on how people
                              should engage with pharma in social media

1.Medical professionals: Work with me

•Improve patient care: Work with me transparently so I can use your expertise to improve our
medicines.
•Listen to me: We have complex regulations we must follow, please understand when we follow them.
•Engage with me: We may be a company but we still want to communicate with you online.
•Communicate with me: A private social media message is often as good as a face to face talk.



2.Patients: We work for you

•We cannot give you personal medical advice: If it is a personal medical matter, see your healthcare
professional for advice.
•Report suspected side effects: We need to understand our medicines better, and you have the
knowledge we need.
•We are listening: Tell us how we can help improve your care, because sometimes we might be able to
help.




                                                                                                  4
Open access social media
                                                                guidelines for pharma



            4                          How should pharma
                                        use social media?
                                             Key Principles

Social media is a fundamental part of how the internet works. People expect social media. They expect
to engage with and discuss your content. You need to work out how to let them.

You must:

•Be transparent. Clearly state who you are and what your intent is.

•Clarify you intent. Make sure the rationale behind your activity is made clear.

•Select your audience. Certain activities are only appropriate for specific audiences. Ensure we know
who you are trying to reach.

•Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to
ensure that information is balanced, informative and non-promotional.

•Facilitate Adverse Event reporting. Report all those you see and make it easy for other people to
report.

•Declare conflicts of interest. Make sure we know who you work closely with. We can then judge their
comments understanding any potential bias.

•Follow their rules. Social media providers have rules for a good reason, so follow them. If you can’t,
help them understand your point of view so they can change them.




                                                                                                      5
Open access social media
                                                               guidelines for pharma



            4                          How should pharma
                                        use social media?
                                            Key Principles

When engaging in social media, consider how to:

•Be human. Ensure that you engage with people as people. Explain what you are doing and why,
particularly if you are moderating comments.

•Be helpful. Answer questions and link to additional information. Direct enquiries you can’t answer
elsewhere, perhaps to their doctor or your medical information department, with a clear explanation
why.

•Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your
industry.

•Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You
don’t have to be online 24/7.

•Enable social sharing. Sharing content and discussing it elsewhere are important but consider who
you provided the content for and where it is shared.

•Enable comments. Social media is all about engagement and discussion so enable comments where
possible.

•Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will
moderate and why. Publish your moderation policy.

•Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People
don’t like this. Remove the comment and explain why.

•Manage negativity. Gently engage with people making inappropriate comments and explain your
point of view, particularly if you are moderating the comments.

•Stop when finished. Close finished campaigns and redirect people to other places.



                                                                                                      6
Open access social media
                                                                guidelines for pharma



            5                          How should pharma
                                         use Wikipedia?
               Wikipedia is not a patient guide or drug formulary, it is an encyclopedia.

Companies are in a unique position to provide additional knowledge. We’d love every article about a
drug to contain information about its regulatory status around the world, its development, its
manufacturing process, and its commercial history, such as the companies that developed it and the
annual sales.

We believe that you can freely edit Wikipedia articles about your medicines if you follow the following
principles.

Consider how to:

•Be transparent. Clearly state who you are and what your intent is.
•Clarify you intent. Make the rationale for the edit clear in the Edit history or on the Discussion page.
•Do not promote. Do not edit an article to promote your medicine.
•Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your
industry.
•Select your audience. Ensure we know who the edit is for clarify which country license applies where
appropriate.
•Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to
ensure that information is balanced, informative and non-promotional.

You may also wish to:
•Suggest edits. Suggest edits on the Discussion page for other editors to make. But you still need to be
transparent about who you are and explain your rationale.
•Appoint a specific company spokesperson. To be the point of contact for your medicine.

  See Wikipedia:Manual of Style/Medicine-related articles and Wikipedia:Identifying reliable sources
       (medicine) for details and feel free to ask the community if you need help on Wikipedia
                                    talk:WikiProject Pharmacology.




                                                                                                       7
Open access social media
                                                                  guidelines for pharma



             6                           How should pharma
                                           use Facebook?
Facebook is a very important place to be. It can be used for promoting certain medicines in some
countries, but many countries do not allow direct to consumer advertising. In these countries it is still
very important for non-promotional activities like patient recruitment into clinical trials and raising
disease awareness.

People expect companies to behave in a certain way on Facebook. The Key Principles above will help
you meet these expectations.

Consider how to:

•Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You
don’t have to be online 24/7.

•Enable comments. Social media is all about engagement and discussion so enable comments where
possible.

•Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will
moderate and why.

•Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People
don’t like this. Remove the comment and explain why.

•Manage negativity. Gently engage with people making inappropriate comments and explain your
point of view, particularly if you are moderating the comments.

•Stop when finished. Close finished campaigns and redirect people to other places.

•Be clear: Provide information about the company with contact details and clearly state who publishes
comments on behalf of the company. People prefer talking with a real person, not a brand or a company.




                                                                                                            8
Open access social media
                                                                guidelines for pharma



            7                          How should pharma
                                          use Twitter?
Twitter is useful for publishing quick updates about a company’s activities. Link tweets back to your
own websites to provide your followers quick access to your important news and information.

Consider how to:

•Be informative. For example, publish corporate news and non-promotional information.

•Select your audience. Use different accounts for different audiences so that people can follow content
which is tailored and appropriate for them. Examples include investors, shareholders, journalists, job
seekers, patients and customers.

•Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to
ensure that information is balanced, informative and non-promotional.

•Be helpful. Answer questions and link to additional information. Direct enquiries you can’t answer
elsewhere, perhaps to their doctor or your medical information department, with a clear explanation
why.

•Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You
don’t have to be online 24/7.

•Publish more than 140 chars. Use longer messages with services like Twitlonger to include additional
information.

Be clear: Provide information about the company with contact details and clearly state who publishes
tweets on behalf of the company. People prefer talking with a real person, not a brand or a company.




                                                                                                        9
Open access social media
                                                               guidelines for pharma



            8                          How should pharma
                                          write blogs?
Blogs are an excellent way for a company to begin its journey into social media. They enable close
control of the content because the articles can be written and approved entirely by the company. The
content can be updated in the companies own timeframes, perhaps weekly, monthly or even less
frequently!

Furthermore, it is one of the few social media tools where it is acceptable to pre-moderate comments.
Your blog readers know that it is owned by you, so they understand if you want to only publish the
comments you find acceptable.

Consider how to:

•Be human. Ensure that you engage with people as people. Explain what you are doing and why,
particularly if you are moderating comments.

•Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your
industry.

•Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to
ensure that information is balanced, informative and non-promotional.

•Enable comments. Blogs work best with discussion so enable comments if you can.

•Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will
moderate and why. Publish your moderation policy.

•Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People
don’t like this. Remove the comment and explain why.

•Manage negativity. Gently engage with people making inappropriate comments and explain your
point of view, particularly if you are moderating the comments.

•Deal with blogging issues: Declare the license you use for the content you publish on your blog.
Provide clear blog description and contact information. Disclaimer and author information are also
needed.


                                                                                                       10
Open access social media
                                                                  guidelines for pharma



             9                          How should pharma
                                          use Youtube?
Like Facebook, YouTube is a public place. You can restrict access to your videos if you need to, but
YouTube is really to “broadcast yourself” or your company.

Use YouTube channels for your company news and specific campaigns. Update them regularly or have
them as a static video library. There are many ways to make YouTube a key part of any digital activity.

Generally speaking, if you have a video appropriate for the public, then you’re mad if you don’t put it
on YouTube. After all, it generates the worlds second largest number of searches after Google itself.

Consider how to:

•Be transparent. If it’s your content, it should be your channel. Or at least clearly state your
involvement

•Avoid direct to consumer promotion. YouTube is a public place so you should only share
promotional videos if permitted by your regulations.

•Enable comments. Social media is all about engagement and discussion so enable comments where
possible.

•Manage negativity. Gently engage with people making inappropriate comments and explain your
point of view, particularly if you are moderating the comments.

•Stop when finished. Close finished campaigns and redirect people to other places.

Be clear: Provide information about the company with contact details and clearly state who publishes
comments on behalf of the company. People prefer talking with a real person, not a brand or a company.

•Tag: Tag videos properly in order to help people find your content.




                                                                                                       11
Open access social media
                                     guidelines for pharma



  10                   Acknowledgement

                       Main editors:

               Dr. Bertalan Mesko (@Berci)
            Dr. Felix Jackson (@felixjackson)
            Silja Chouquet (@whydotpharma)
             Andrew Spong (@andrewspong)
             Denise Silber (@health20paris)
                   Rob Halkes (@rohal)

And hundreds of collaborators sending suggestions, leaving
          comments and spreading the word.

Please join us on Webicina , see the Google Docs page, and
let’s create an extended, even more detailed second version!

 Show your support or give us feedback on Twitter using
                  #pharmaSMguide




                                                           12
Open access social media
                       guidelines for pharma



 11             Contact us!


Please feel free to contact us if you
       have any questions!

        info@webicina.com

         Twitter.com/Berci

          Skype: ncurse




                                           13

More Related Content

Similar to Webicina Open access social media guidelines for pharma

5530: Chapter 22
5530: Chapter 225530: Chapter 22
5530: Chapter 22bodo-con
 
Knowledge Exchange with Policy Impact
Knowledge Exchange with Policy ImpactKnowledge Exchange with Policy Impact
Knowledge Exchange with Policy ImpactWellesley Institute
 
5530: Chapter 16
5530: Chapter 165530: Chapter 16
5530: Chapter 16bodo-con
 
A case study on the effectual factors for
A case study on the effectual factors forA case study on the effectual factors for
A case study on the effectual factors forSharanya Shri
 
Is Anybody Reading This? Writing Content for the Web
Is Anybody Reading This? Writing Content for the WebIs Anybody Reading This? Writing Content for the Web
Is Anybody Reading This? Writing Content for the WebMark Figart
 
Social media ethics - NetSquared Tech Valley
Social media ethics   - NetSquared Tech ValleySocial media ethics   - NetSquared Tech Valley
Social media ethics - NetSquared Tech ValleyTim Sarrantonio
 
The pull side_of_social_media (08-11)
The pull side_of_social_media (08-11)The pull side_of_social_media (08-11)
The pull side_of_social_media (08-11)Balvor LLC
 
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...Autism Private Health Insurance Impact on the IEP - Special Education Attorne...
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...bordeauxmktg
 
How to Acquire and Engage Patients With Social Media
How to Acquire and Engage Patients With Social MediaHow to Acquire and Engage Patients With Social Media
How to Acquire and Engage Patients With Social MediaPatientPop
 
5530: Chapter 8
5530: Chapter 85530: Chapter 8
5530: Chapter 8bodo-con
 
Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copieJulien Dagher
 
A study of impact of social media on consumer behaviour
A study of impact of social media on consumer behaviour A study of impact of social media on consumer behaviour
A study of impact of social media on consumer behaviour ChidanandaChidu5
 
5530: Chapter 23
5530: Chapter 235530: Chapter 23
5530: Chapter 23bodo-con
 
Leveraging the power of social media in healthcare research
Leveraging the power of social media in healthcare researchLeveraging the power of social media in healthcare research
Leveraging the power of social media in healthcare researchInSites on Stage
 
Presentation of Noral Capabilities
Presentation of Noral CapabilitiesPresentation of Noral Capabilities
Presentation of Noral Capabilitiesjnestor
 
Keynote Conversation: Spreading the Social Media Revolution
Keynote Conversation: Spreading the Social Media RevolutionKeynote Conversation: Spreading the Social Media Revolution
Keynote Conversation: Spreading the Social Media RevolutionLee Aase
 
5530: Chapter 11
5530: Chapter 115530: Chapter 11
5530: Chapter 11bodo-con
 
Mental Health and Digital Safety Tips for Journalists.pptx
Mental Health and Digital Safety Tips for Journalists.pptxMental Health and Digital Safety Tips for Journalists.pptx
Mental Health and Digital Safety Tips for Journalists.pptxDamian Radcliffe
 

Similar to Webicina Open access social media guidelines for pharma (20)

5530: Chapter 22
5530: Chapter 225530: Chapter 22
5530: Chapter 22
 
Knowledge Exchange with Policy Impact
Knowledge Exchange with Policy ImpactKnowledge Exchange with Policy Impact
Knowledge Exchange with Policy Impact
 
5530: Chapter 16
5530: Chapter 165530: Chapter 16
5530: Chapter 16
 
A case study on the effectual factors for
A case study on the effectual factors forA case study on the effectual factors for
A case study on the effectual factors for
 
Social Media 101
Social Media 101Social Media 101
Social Media 101
 
Is Anybody Reading This? Writing Content for the Web
Is Anybody Reading This? Writing Content for the WebIs Anybody Reading This? Writing Content for the Web
Is Anybody Reading This? Writing Content for the Web
 
Social media ethics - NetSquared Tech Valley
Social media ethics   - NetSquared Tech ValleySocial media ethics   - NetSquared Tech Valley
Social media ethics - NetSquared Tech Valley
 
The pull side_of_social_media (08-11)
The pull side_of_social_media (08-11)The pull side_of_social_media (08-11)
The pull side_of_social_media (08-11)
 
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...Autism Private Health Insurance Impact on the IEP - Special Education Attorne...
Autism Private Health Insurance Impact on the IEP - Special Education Attorne...
 
How to Acquire and Engage Patients With Social Media
How to Acquire and Engage Patients With Social MediaHow to Acquire and Engage Patients With Social Media
How to Acquire and Engage Patients With Social Media
 
Unniched mo tech
Unniched mo techUnniched mo tech
Unniched mo tech
 
5530: Chapter 8
5530: Chapter 85530: Chapter 8
5530: Chapter 8
 
Future trends in pharma marketing 2016 copie
Future trends in pharma marketing 2016   copieFuture trends in pharma marketing 2016   copie
Future trends in pharma marketing 2016 copie
 
A study of impact of social media on consumer behaviour
A study of impact of social media on consumer behaviour A study of impact of social media on consumer behaviour
A study of impact of social media on consumer behaviour
 
5530: Chapter 23
5530: Chapter 235530: Chapter 23
5530: Chapter 23
 
Leveraging the power of social media in healthcare research
Leveraging the power of social media in healthcare researchLeveraging the power of social media in healthcare research
Leveraging the power of social media in healthcare research
 
Presentation of Noral Capabilities
Presentation of Noral CapabilitiesPresentation of Noral Capabilities
Presentation of Noral Capabilities
 
Keynote Conversation: Spreading the Social Media Revolution
Keynote Conversation: Spreading the Social Media RevolutionKeynote Conversation: Spreading the Social Media Revolution
Keynote Conversation: Spreading the Social Media Revolution
 
5530: Chapter 11
5530: Chapter 115530: Chapter 11
5530: Chapter 11
 
Mental Health and Digital Safety Tips for Journalists.pptx
Mental Health and Digital Safety Tips for Journalists.pptxMental Health and Digital Safety Tips for Journalists.pptx
Mental Health and Digital Safety Tips for Journalists.pptx
 

More from Bertalan Mesko, MD

Medical Social Media Guide to Webicina.com
Medical Social Media Guide to Webicina.comMedical Social Media Guide to Webicina.com
Medical Social Media Guide to Webicina.comBertalan Mesko, MD
 
Medicine in Second Life, the virtual world
Medicine in Second Life, the virtual worldMedicine in Second Life, the virtual world
Medicine in Second Life, the virtual worldBertalan Mesko, MD
 
Practicing Medicine in the Web 2.0 Era
Practicing Medicine in the Web 2.0 EraPracticing Medicine in the Web 2.0 Era
Practicing Medicine in the Web 2.0 EraBertalan Mesko, MD
 
Jason Young: Improving Communication With Cognitively Impaired Patients
Jason Young: Improving Communication With Cognitively Impaired PatientsJason Young: Improving Communication With Cognitively Impaired Patients
Jason Young: Improving Communication With Cognitively Impaired PatientsBertalan Mesko, MD
 
Medical education and building an online reputation in the world of web 2.0
Medical education and building an online reputation in the world of web 2.0Medical education and building an online reputation in the world of web 2.0
Medical education and building an online reputation in the world of web 2.0Bertalan Mesko, MD
 
Medicine 2.0 with the eye of a medical student blogger
Medicine 2.0 with the eye of a medical student bloggerMedicine 2.0 with the eye of a medical student blogger
Medicine 2.0 with the eye of a medical student bloggerBertalan Mesko, MD
 
The impact of web 2.0 on medicine and healthcare
The impact of web 2.0 on medicine and healthcareThe impact of web 2.0 on medicine and healthcare
The impact of web 2.0 on medicine and healthcareBertalan Mesko, MD
 

More from Bertalan Mesko, MD (9)

Medical Social Media Guide to Webicina.com
Medical Social Media Guide to Webicina.comMedical Social Media Guide to Webicina.com
Medical Social Media Guide to Webicina.com
 
Medicine in Second Life, the virtual world
Medicine in Second Life, the virtual worldMedicine in Second Life, the virtual world
Medicine in Second Life, the virtual world
 
Practicing Medicine in the Web 2.0 Era
Practicing Medicine in the Web 2.0 EraPracticing Medicine in the Web 2.0 Era
Practicing Medicine in the Web 2.0 Era
 
Jason Young: Improving Communication With Cognitively Impaired Patients
Jason Young: Improving Communication With Cognitively Impaired PatientsJason Young: Improving Communication With Cognitively Impaired Patients
Jason Young: Improving Communication With Cognitively Impaired Patients
 
Medical education and building an online reputation in the world of web 2.0
Medical education and building an online reputation in the world of web 2.0Medical education and building an online reputation in the world of web 2.0
Medical education and building an online reputation in the world of web 2.0
 
Medicine 2.0 with the eye of a medical student blogger
Medicine 2.0 with the eye of a medical student bloggerMedicine 2.0 with the eye of a medical student blogger
Medicine 2.0 with the eye of a medical student blogger
 
The impact of web 2.0 on medicine and healthcare
The impact of web 2.0 on medicine and healthcareThe impact of web 2.0 on medicine and healthcare
The impact of web 2.0 on medicine and healthcare
 
Jakob Voss Wikipedia2007
Jakob Voss Wikipedia2007Jakob Voss Wikipedia2007
Jakob Voss Wikipedia2007
 
Medicine 2.0
Medicine 2.0Medicine 2.0
Medicine 2.0
 

Recently uploaded

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 

Recently uploaded (20)

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 

Webicina Open access social media guidelines for pharma

  • 1. Open access social media guidelines for pharma December, 2011 First version „A set of guidelines created collaboratively by the most important online voices of pharma and social media designed to facilitate online interaction with and within pharma.” #pharmaSMguide
  • 2. Open access social media guidelines for pharma Table of contents 1) Introduction................................................................2 2) A Physician’s Rules of Engagement...........................3 3) Pharma’s Rules of Engagement..................................4 4) How pharma should use social media........................5 5) How pharma should use Wikipedia...........................7 6) How pharma should use Facebook.............................8 7) How pharma should use Twitter.................................9 8) How pharma should write blogs...............................10 9) How pharma should use Youtube..............................11 10) Acknowledgement...................................................12 11) Contact addresses....................................................13 1
  • 3. Open access social media guidelines for pharma 1 Introduction FDA and other authorities have been trying to deal with the rapid adoption of social media but they have not been able to publish the required guidance about how pharma can engage with social media. At Webicina.com, we decided to launch a project with a mission of creating a set of open access social media guidelines for and about the pharma industry with the help of an expert crowd. This is "the key principles in a manifesto type document" which can be the overview for pharma to follow. The guidance outlines the key principles such as protecting patients, keeping healthcare professionals informed, being transparent, reporting the Adverse Events, or following applicable codes and regulations in social media. After months of hard collaborative work, we now publish „A Physician’s Rules of Engagement”; a „Pharma’s Rules of Engagement”; Key Principles about how pharma should use social media and technology specific guides as well. We hope this guide will initiate an even more extended collaboration and we, healthcare professionals, e-patients and pharma, can facilitate the process for the FDA of publishing its own guide. Show your support or feedback your thoughts on Twitter using #pharmaSMguide. Join this project and see more details including positive and negative pharma-related social media case studies on Webicina! Best regards, Dr. Bertalan Mesko Managing director of Webicina.com & Dr. Felix Jackson Chief Medical Officer of medDigital 2
  • 4. Open access social media guidelines for pharma 2 A Physician’s Rules of Engagement A physician's perspective on how pharma should engage with physicians in social media 1) Work with me to improve my patient's care: •Understand my needs. Make it easy for me to access your expertise and listen to me online. •Engage with me. Don't just promote or try to influence me. •Communicate with me. Using both online and offline channels. •Protect my private data. Both my personal data and my clinical research data. •Get my permission. You have my permission when I've given it to you. 2) Keep our patients safe: •Conduct ethical research. And communicate your successes online. •Manufacture the best medicines. Maintaining the highest standards of quality. •Market only licensed medicines. And keep me informed even online about those in development. •Be transparent in everything you do. Or someone else will be on your behalf! •Improve your knowledge. Understand and report adverse events on your medicines by listening online. 3) Work with each other: •Stay within your codes and regulations. Use these principles with your codes and regulations to understand your responsibilities. •Share your learnings. Share your metrics to identify success and understand failure across the industry. •Improve your codes and regulations. Give and share feedback to improve these principles. Use these principles to revise your codes and regulations. 3
  • 5. Open access social media guidelines for pharma 3 Pharma’s Rules of Engagement Pharma’s perspective on how people should engage with pharma in social media 1.Medical professionals: Work with me •Improve patient care: Work with me transparently so I can use your expertise to improve our medicines. •Listen to me: We have complex regulations we must follow, please understand when we follow them. •Engage with me: We may be a company but we still want to communicate with you online. •Communicate with me: A private social media message is often as good as a face to face talk. 2.Patients: We work for you •We cannot give you personal medical advice: If it is a personal medical matter, see your healthcare professional for advice. •Report suspected side effects: We need to understand our medicines better, and you have the knowledge we need. •We are listening: Tell us how we can help improve your care, because sometimes we might be able to help. 4
  • 6. Open access social media guidelines for pharma 4 How should pharma use social media? Key Principles Social media is a fundamental part of how the internet works. People expect social media. They expect to engage with and discuss your content. You need to work out how to let them. You must: •Be transparent. Clearly state who you are and what your intent is. •Clarify you intent. Make sure the rationale behind your activity is made clear. •Select your audience. Certain activities are only appropriate for specific audiences. Ensure we know who you are trying to reach. •Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to ensure that information is balanced, informative and non-promotional. •Facilitate Adverse Event reporting. Report all those you see and make it easy for other people to report. •Declare conflicts of interest. Make sure we know who you work closely with. We can then judge their comments understanding any potential bias. •Follow their rules. Social media providers have rules for a good reason, so follow them. If you can’t, help them understand your point of view so they can change them. 5
  • 7. Open access social media guidelines for pharma 4 How should pharma use social media? Key Principles When engaging in social media, consider how to: •Be human. Ensure that you engage with people as people. Explain what you are doing and why, particularly if you are moderating comments. •Be helpful. Answer questions and link to additional information. Direct enquiries you can’t answer elsewhere, perhaps to their doctor or your medical information department, with a clear explanation why. •Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your industry. •Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You don’t have to be online 24/7. •Enable social sharing. Sharing content and discussing it elsewhere are important but consider who you provided the content for and where it is shared. •Enable comments. Social media is all about engagement and discussion so enable comments where possible. •Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will moderate and why. Publish your moderation policy. •Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People don’t like this. Remove the comment and explain why. •Manage negativity. Gently engage with people making inappropriate comments and explain your point of view, particularly if you are moderating the comments. •Stop when finished. Close finished campaigns and redirect people to other places. 6
  • 8. Open access social media guidelines for pharma 5 How should pharma use Wikipedia? Wikipedia is not a patient guide or drug formulary, it is an encyclopedia. Companies are in a unique position to provide additional knowledge. We’d love every article about a drug to contain information about its regulatory status around the world, its development, its manufacturing process, and its commercial history, such as the companies that developed it and the annual sales. We believe that you can freely edit Wikipedia articles about your medicines if you follow the following principles. Consider how to: •Be transparent. Clearly state who you are and what your intent is. •Clarify you intent. Make the rationale for the edit clear in the Edit history or on the Discussion page. •Do not promote. Do not edit an article to promote your medicine. •Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your industry. •Select your audience. Ensure we know who the edit is for clarify which country license applies where appropriate. •Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to ensure that information is balanced, informative and non-promotional. You may also wish to: •Suggest edits. Suggest edits on the Discussion page for other editors to make. But you still need to be transparent about who you are and explain your rationale. •Appoint a specific company spokesperson. To be the point of contact for your medicine. See Wikipedia:Manual of Style/Medicine-related articles and Wikipedia:Identifying reliable sources (medicine) for details and feel free to ask the community if you need help on Wikipedia talk:WikiProject Pharmacology. 7
  • 9. Open access social media guidelines for pharma 6 How should pharma use Facebook? Facebook is a very important place to be. It can be used for promoting certain medicines in some countries, but many countries do not allow direct to consumer advertising. In these countries it is still very important for non-promotional activities like patient recruitment into clinical trials and raising disease awareness. People expect companies to behave in a certain way on Facebook. The Key Principles above will help you meet these expectations. Consider how to: •Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You don’t have to be online 24/7. •Enable comments. Social media is all about engagement and discussion so enable comments where possible. •Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will moderate and why. •Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People don’t like this. Remove the comment and explain why. •Manage negativity. Gently engage with people making inappropriate comments and explain your point of view, particularly if you are moderating the comments. •Stop when finished. Close finished campaigns and redirect people to other places. •Be clear: Provide information about the company with contact details and clearly state who publishes comments on behalf of the company. People prefer talking with a real person, not a brand or a company. 8
  • 10. Open access social media guidelines for pharma 7 How should pharma use Twitter? Twitter is useful for publishing quick updates about a company’s activities. Link tweets back to your own websites to provide your followers quick access to your important news and information. Consider how to: •Be informative. For example, publish corporate news and non-promotional information. •Select your audience. Use different accounts for different audiences so that people can follow content which is tailored and appropriate for them. Examples include investors, shareholders, journalists, job seekers, patients and customers. •Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to ensure that information is balanced, informative and non-promotional. •Be helpful. Answer questions and link to additional information. Direct enquiries you can’t answer elsewhere, perhaps to their doctor or your medical information department, with a clear explanation why. •Respond quickly. Organize your internal approvals to ensure responses happen within 48 hours. You don’t have to be online 24/7. •Publish more than 140 chars. Use longer messages with services like Twitlonger to include additional information. Be clear: Provide information about the company with contact details and clearly state who publishes tweets on behalf of the company. People prefer talking with a real person, not a brand or a company. 9
  • 11. Open access social media guidelines for pharma 8 How should pharma write blogs? Blogs are an excellent way for a company to begin its journey into social media. They enable close control of the content because the articles can be written and approved entirely by the company. The content can be updated in the companies own timeframes, perhaps weekly, monthly or even less frequently! Furthermore, it is one of the few social media tools where it is acceptable to pre-moderate comments. Your blog readers know that it is owned by you, so they understand if you want to only publish the comments you find acceptable. Consider how to: •Be human. Ensure that you engage with people as people. Explain what you are doing and why, particularly if you are moderating comments. •Speak plainly. No jargon, no technical words. Keep in mind you are talking to people outside your industry. •Understand your medicine’s licence. Care needs to be taken when referring to off-licence data to ensure that information is balanced, informative and non-promotional. •Enable comments. Blogs work best with discussion so enable comments if you can. •Avoid moderation. If you have to moderate, try not to pre-moderate and clearly state what you will moderate and why. Publish your moderation policy. •Avoid editing comments. Do not edit the comments you moderate as it changes the meaning. People don’t like this. Remove the comment and explain why. •Manage negativity. Gently engage with people making inappropriate comments and explain your point of view, particularly if you are moderating the comments. •Deal with blogging issues: Declare the license you use for the content you publish on your blog. Provide clear blog description and contact information. Disclaimer and author information are also needed. 10
  • 12. Open access social media guidelines for pharma 9 How should pharma use Youtube? Like Facebook, YouTube is a public place. You can restrict access to your videos if you need to, but YouTube is really to “broadcast yourself” or your company. Use YouTube channels for your company news and specific campaigns. Update them regularly or have them as a static video library. There are many ways to make YouTube a key part of any digital activity. Generally speaking, if you have a video appropriate for the public, then you’re mad if you don’t put it on YouTube. After all, it generates the worlds second largest number of searches after Google itself. Consider how to: •Be transparent. If it’s your content, it should be your channel. Or at least clearly state your involvement •Avoid direct to consumer promotion. YouTube is a public place so you should only share promotional videos if permitted by your regulations. •Enable comments. Social media is all about engagement and discussion so enable comments where possible. •Manage negativity. Gently engage with people making inappropriate comments and explain your point of view, particularly if you are moderating the comments. •Stop when finished. Close finished campaigns and redirect people to other places. Be clear: Provide information about the company with contact details and clearly state who publishes comments on behalf of the company. People prefer talking with a real person, not a brand or a company. •Tag: Tag videos properly in order to help people find your content. 11
  • 13. Open access social media guidelines for pharma 10 Acknowledgement Main editors: Dr. Bertalan Mesko (@Berci) Dr. Felix Jackson (@felixjackson) Silja Chouquet (@whydotpharma) Andrew Spong (@andrewspong) Denise Silber (@health20paris) Rob Halkes (@rohal) And hundreds of collaborators sending suggestions, leaving comments and spreading the word. Please join us on Webicina , see the Google Docs page, and let’s create an extended, even more detailed second version! Show your support or give us feedback on Twitter using #pharmaSMguide 12
  • 14. Open access social media guidelines for pharma 11 Contact us! Please feel free to contact us if you have any questions! info@webicina.com Twitter.com/Berci Skype: ncurse 13